FindTrial
Sign In

Frequency: day 01 and day 08

2 trials

Sponsors

Intas Pharmaceuticals Limited, Alembic Pharmaceuticals Limited

Conditions

Health Condition 1: L40- Psoriasis Health Condition 2: M069- Rheumatoid arthritis, unspecifiedHealth Condition 1: M069- Rheumatoid arthritis, unspecified

Unknown Phase

A Study of Methotrexate Tablets 2.5 mg in Adult Patients with Inflammatory Disorder of many joints and/or Patches of Abnormal Skin
Active, not recruitingCTRI/2018/11/016245
Intas Pharmaceuticals LimitedHealth Condition 1: M069- Rheumatoid arthritis, unspecified
Target: 42Updated: 2021-11-24
A Study of Methotrexate Tablets 2.5 mg in Adult Patients with Mild to Severe Psoriasis or Rheumatoid Arthritis
Active, not recruitingCTRI/2021/08/035480
Alembic Pharmaceuticals LimitedHealth Condition 1: L40- Psoriasis Health Condition 2: M069- Rheumatoid arthritis, unspecified
Target: 48Updated: 2024-10-14